{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T17:09:58Z","timestamp":1722445798339},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,8,5]],"date-time":"2005-08-05T00:00:00Z","timestamp":1123200000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1007\/s00467-005-1954-1","type":"journal-article","created":{"date-parts":[[2005,8,4]],"date-time":"2005-08-04T11:42:45Z","timestamp":1123155765000},"page":"1701-1707","source":"Crossref","is-referenced-by-count":2,"title":["Assessing cardiovascular risk in children with chronic kidney disease. B-type natriuretic peptide: a potential new marker"],"prefix":"10.1007","volume":"20","author":[{"given":"Gema","family":"Ariceta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen R.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig B.","family":"Langman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,8,5]]},"reference":[{"key":"1954_CR1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1067\/mpd.2002.126921","volume":"141","author":"Mitsnefes","year":"2002","unstructured":"Mitsnefes MM (2002) Pediatric end-stage renal disease: heart as target. J Pediatr 141:162\u2013164","journal-title":"J Pediatr"},{"key":"1954_CR2","unstructured":"The USRDS 2004 Annual Report (2004) Pediatric end-stage renal disease.http:\/\/www.usrds.org"},{"key":"1954_CR3","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1046\/j.1523-1755.2003.00814.x","volume":"63","author":"Gruppen","year":"2003","unstructured":"Gruppen MP, Groothoff JW, Prins M, et al (2003) Cardiac disease in young adult patients with end-stage renal disease since childhood: a Dutch cohort study. Kidney Int 63:1058\u20131065","journal-title":"Kidney Int"},{"key":"1954_CR4","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1067\/mpd.2002.125910","volume":"141","author":"Parekh","year":"2002","unstructured":"Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191\u2013197","journal-title":"J Pediatr"},{"key":"1954_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJM199807303390507","volume":"339","author":"Levin","year":"1998","unstructured":"Levin RE, Gardner DG, Samson WK (1998) Natriuretic peptides. N Engl J Med 339:321\u2013328","journal-title":"N Engl J Med"},{"key":"1954_CR6","first-page":"155","volume":"45","author":"Kyuma","year":"2004","unstructured":"Kyuma M, Nkata T, Hshimoto A, Nagao K, Sasao H, Takahshi T, Tsuchihashi K, Shimamoto K (2004) Incremental prognosis implications of brain natriuretic peptide, cardiac sympathetic nerve innervations and noncardiac disorders in patients with heart failure. J Nucl Med 45:155\u2013163","journal-title":"J Nucl Med"},{"key":"1954_CR7","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.HYP.28.6.988","volume":"28","author":"Yamamoto","year":"1996","unstructured":"Yamamoto K, Burnet JC, Jougasaki M, Nishimura RA, Bailey KR, Saito K, Nakao K, Redfield MM (1996) Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28:988\u2013994","journal-title":"Hypertension"},{"key":"1954_CR8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1161\/01.HYP.28.1.22","volume":"28","author":"Nishikimi","year":"1996","unstructured":"Nishikimi T, Yoshihara F, Morimoto A, Ishikawa K, Ishimitsu T, Saito Y, Kangawa K, Matsuo H, Omae T, Matsuoka H (1996) Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 28:22\u201330","journal-title":"Hypertension"},{"key":"1954_CR9","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1053\/ajkd.2001.24523","volume":"37","author":"Nishikimi","year":"2001","unstructured":"Nishikimi T, Futoo Y, Tamano K, Takahashi M, Suzuki T, Minami J, et al (2001) Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease. Am J kidney Dis 37:1201\u20131208","journal-title":"Am J kidney Dis"},{"key":"1954_CR10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0272-6386(12)80903-6","volume":"24","author":"Ishizaka","year":"1994","unstructured":"Ishizaka Y, Yamamoto Y, Fukunaga T, et al (1994) Plasma concentration of human brain natriuretic peptide in patients on hemodialysis. Am J Kidney Dis 24:46\u201372","journal-title":"Am J Kidney Dis"},{"key":"1954_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1651-2227.2004.tb02958.x","volume":"93","author":"Westerlind","year":"2004","unstructured":"Westerlind A, Wahlander H, Lindstedt G, Lumberg PA, Holmgren D (2004) Clinical signs of heart failure are associated with increased levels of natriuretic peptides types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 93:340\u2013345","journal-title":"Acta Paediatr"},{"key":"1954_CR12","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.amjcard.2003.08.035","volume":"92","author":"Claudius","year":"2003","unstructured":"Claudius I, Lan YT, Chang RK, Wetzel GT, Alejos J (2003) Usefulness of B-type natriuretic peptide as noninvasive screening tool for cardiac allograft pathology in pediatric heart transplant recipients. Am J Cardiol 92:1368\u20131370","journal-title":"Am J Cardiol"},{"key":"1954_CR13","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1210\/er.2003-0006","volume":"24","author":"Ruskoaho","year":"2003","unstructured":"Ruskoaho H (2003) Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 24:341\u2013356","journal-title":"Endocr Rev"},{"key":"1954_CR14","unstructured":"National Kidney Foundation Kidney Disease Outcomes Quality Initiative (2003) Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 41 [Suppl]:S1\u2013S91"},{"key":"1954_CR15","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1161\/01.CIR.0000020222.63035.C0","volume":"106","author":"Oh","year":"2002","unstructured":"Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100\u2013105","journal-title":"Circulation"},{"key":"1954_CR16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1053\/snep.2002.35666","volume":"22","author":"Dhingra","year":"2002","unstructured":"Dhingra H, Roongsritong C, Kurtzman NA (2002) Brain natriuretic peptide: role in cardiovascular and volume homeostasis. Semin Nephrol 22:423\u2013437","journal-title":"Semin Nephrol"},{"key":"1954_CR17","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1210\/en.2003-0127","volume":"144","author":"Cameron","year":"2003","unstructured":"Cameron VA, Ellmers LJ (2003) Minireview: natriuretic peptides during development of the fetal heart and circulation. Endocrinology 144:2191\u20132194","journal-title":"Endocrinology"},{"key":"1954_CR18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(03)13976-1","volume":"362","author":"de","year":"2003","unstructured":"de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316\u2013322","journal-title":"Lancet"},{"key":"1954_CR19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1373\/clinchem.2003.027557","volume":"50","author":"Jortani","year":"2004","unstructured":"Jortani SA, Prabbu SD, Valdes R (2004) Strategies for developing biomarkers of heart failure. Clin Chem 50:265\u2013278","journal-title":"Clin Chem"},{"key":"1954_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1373\/clinchem.2003.024760","volume":"50","author":"Clerico","year":"2004","unstructured":"Clerico A, Emdin M (2004) Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50:33\u201350","journal-title":"Clin Chem"},{"key":"1954_CR21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1530\/eje.0.1330207","volume":"133","author":"Yoshibayashi","year":"1995","unstructured":"Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S, et al (1995) Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 133:207\u2013209","journal-title":"Eur J Endocrinol"},{"key":"1954_CR22","first-page":"191","volume":"57","author":"Kunii","year":"2003","unstructured":"Kunii Y, Kamada M, Ohtsuki S, Araki T, et al (2003) Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 57:191\u2013197","journal-title":"Acta Med Okayama"},{"key":"1954_CR23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/heart.89.8.875","volume":"89","author":"Koch","year":"2003","unstructured":"Koch A, Singer H (2003) Normal values of B type natriuretic peptide in infants, children and adolescents. Heart 89:875\u2013878","journal-title":"Heart"},{"key":"1954_CR24","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0735-1097(02)02059-4","volume":"40","author":"Redfield","year":"2002","unstructured":"Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC (2002) Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 40:976\u2013982","journal-title":"J Am Coll Cardiol"},{"key":"1954_CR25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.0000081657.83724.A7","volume":"108","author":"Wang","year":"2003","unstructured":"Wang TJ, Larson MG, Levy D, et at (2003) Heritability and genetic linkage of plasma natriuretic peptide levels. Circulation 108:13\u201316","journal-title":"Circulation"},{"key":"1954_CR26","first-page":"595","volume":"109","author":"Wang","year":"2004","unstructured":"Wang TJ, Larson MG, Levy D, Benjamin EJ, Corey D, Leip EP, et al (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109:595\u2013600","journal-title":"Circulation"},{"key":"1954_CR27","unstructured":"McCullough PA, Sandberg KR (2003) Sorting out the evidence on natriuretic peptides. Rev Cardiovasc Med 4[Suppl\u00a04]: S13\u2013S19"},{"key":"1954_CR28","first-page":"457","volume":"10","author":"Nakatami","year":"2002","unstructured":"Nakatami T, Nagamuna T, Masuda C, Uchida J, Sugimura T, Sugimura K (2002) Significance of brain natriuretic peptides in patients on continuous ambulatory peritoneal dialysis. Int J Mol Med 10:457\u2013461","journal-title":"Int J Mol Med"},{"key":"1954_CR29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000065272","volume":"22","author":"Naganuma","year":"2002","unstructured":"Naganuma T, Sugimura K, Wada S, et al (2002) The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22:437\u2013444","journal-title":"Am J Nephrol"},{"key":"1954_CR30","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S0272-6386(04)00812-1","volume":"44","author":"Takami","year":"2004","unstructured":"Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F, et al (2004) Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent CRF. Am J Kidney Dis 44:420","journal-title":"Am J Kidney Dis"},{"key":"1954_CR31","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1210\/jcem.84.7.5819","volume":"84","author":"Yano","year":"1999","unstructured":"Yano Y, Katsuki A, Gabazza EC, Ito K, Fujii M, Furuta M, et al (1999) Plasma brain natriuretic peptide levels in normotensive noninsulin-dependent diabetic patients with microalbuminuria. J Clin Endocrinol Metab 84:2353\u20132356","journal-title":"J Clin Endocrinol Metab"},{"key":"1954_CR32","unstructured":"Biosite (2002) TriageBNP package insert. Biosite, San Diego"},{"key":"1954_CR49","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1053\/ajkd.2003.50118","volume":"41","author":"McCullough","year":"2003","unstructured":"McCullough PA, Duc P, Omland T, et al (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am J Kidney Dis 41:571\u2013579","journal-title":"Am J Kidney Dis"},{"key":"1954_CR33","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1373\/clinchem.2003.021311","volume":"49","author":"Ishii","year":"2003","unstructured":"Ishii J, Cui W, Kitagawa F, et al (2003) Prognostic value of combination of cardiac troponin\u00a0T and B-type natriuretic peptide after initiation of treatment in patients with chronic heart failure. Clin Chem 49:2020\u20132026","journal-title":"Clin Chem"},{"key":"1954_CR34","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1373\/clinchem.2004.038752","volume":"50","author":"Bruins","year":"2004","unstructured":"Bruins S, Fokkema MR. Romer JWP, et al (2004) High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure. Clin Chem 50:2052\u20132058","journal-title":"Clin Chem"},{"key":"1954_CR35","doi-asserted-by":"crossref","unstructured":"Kurotobi S, Kawakami N, Shimizu K, et al (2005) Brain natriuretic peptide as a hormonal marker of ventricular diastolic dysfunction in children with Kawasaki Disease. Pediatr Cardiol, Han 13, Epub ahead of print","DOI":"10.1007\/s00246-004-0812-4"},{"key":"1954_CR36","doi-asserted-by":"crossref","unstructured":"Suda K, Matsumura M, Matsumoto M. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 45:249\u2013254","DOI":"10.1046\/j.1442-200X.2003.01716.x"},{"key":"1954_CR37","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S1053-2498(03)00306-1","volume":"23","author":"Lan","year":"2004","unstructured":"Lan YT, Chang RKR, Alejos JC, Burch C, Wetzel GT (2004) B-type natriuretic peptide in children after cardiac transplantation. J Heart Lung Transplant 23:558\u2013563","journal-title":"J Heart Lung Transplant"},{"key":"1954_CR38","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/00004872-199816090-00005","volume":"16","author":"Kario","year":"1998","unstructured":"Kario K, Nishikimi T, Toshikaara F, Takishita S, Yamakoa R, Matsuo T, Matuso H, Mithuhashi T, Shimada K, Kangawa K (1998) Plasma levels of natriuretic peptides and adrenomedullin in elderly hypertensive patients: relationships to 24\u00a0h blood pressure. J Hypertens 16:1253\u20131259","journal-title":"J Hypertens"},{"key":"1954_CR39","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0895-7061(03)00567-3","volume":"16","author":"Hoshide","year":"2003","unstructured":"Hoshide S, Kario K, Hoshide Y, Umeda Y, Hashimoto T, Kunii O, Ojima T, Shimada K (2003) Associations between nondipping of nocturnal blood pressure decrease and cardiovascular target organ damage in strictly selected community-dwelling normotensives. Am J Hypertens 16:434\u2013438","journal-title":"Am J Hypertens"},{"key":"1954_CR40","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1291\/hypres.25.887","volume":"25","author":"Kato","year":"2002","unstructured":"Kato J, Kitamura K, Uemura T, et al (2002) Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res 25:887\u2013892","journal-title":"Hypertens Res"},{"key":"1954_CR41","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/01.HYP.0000061116.20490.8D","volume":"41","author":"Freitag","year":"2003","unstructured":"Freitag MH, Laron MG, Levy D, Benjamin EJ, et al (2003) Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension 41:978\u2013983","journal-title":"Hypertension"},{"key":"1954_CR42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000069763","volume":"26","author":"Mussalo","year":"2003","unstructured":"Mussalo H, Vanninen E, Ik\u00e4heimo R, Hartikainen J (2003) NT-proANP and BNP in renovascular and in severe and mild essential hypertension. Kidney Blood Press Res 26:34\u201341","journal-title":"Kidney Blood Press Res"},{"key":"1954_CR43","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1291\/hypres.25.669","volume":"25","author":"Suzuki","year":"2002","unstructured":"Suzuki M, Hamada M, Yamamoto K, Kazatani Y, Hiwada K (2002) Brain natriuretic peptide as a risk marker for incident hypertensive cardiovascular events. Hypertens Res 25:669\u2013676","journal-title":"Hypertens Res"},{"key":"1954_CR44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2362.2004.01348.x","volume":"34","author":"Grandi","year":"2004","unstructured":"Grandi AM, Laurita E, Selva E, Piantanida E, Imperiale D, Giovanella L, et al (2004) Natriuretic peptides as markers of preclinical cardiac disease in obesity. Eur J Clin Invest 34:342\u2013348","journal-title":"Eur J Clin Invest"},{"key":"1954_CR45","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0272-6386(03)00358-5","volume":"41","author":"Lee","year":"2003","unstructured":"Lee SW, Song JH, Kim GA, Lim HJ, Kim MJ (2003) Plasma brain natriuretic peptide concentration on assessment of hydration status in hemodialysis patient. Am J Kidney Dis 41:1257\u20131266","journal-title":"Am J Kidney Dis"},{"key":"1954_CR46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4065\/76.11.1111","volume":"76","author":"Cataliotti","year":"2001","unstructured":"Cataliotti A, Malatino LS, Jougasaki M, et al (2001) Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 76:1111\u20131119","journal-title":"Mayo Clin Proc"},{"key":"1954_CR47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1159\/000064100","volume":"92","author":"Goto","year":"2002","unstructured":"Goto T, Takase H, Toriyama T, et al (2002) Increased circulating levels of natriuretic peptides predict future cardiac event in patients with chronic hemodialysis. Nephron 92:610\u2013615","journal-title":"Nephron"},{"key":"1954_CR48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1159\/000065272","volume":"22","author":"Naganuma","year":"2002","unstructured":"Naganuma T, Sugimura K, Wada S, et al (2002) The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 22:437\u2013444","journal-title":"Am J Nephrol"},{"key":"1954_CR50","first-page":"16","volume":"5","author":"McCullough","year":"2004","unstructured":"McCullough PA, Joseph K, Mathur VS (2004) Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure. Rev Cardiovasc Med 5:16\u201325","journal-title":"Rev Cardiovasc Med"},{"key":"1954_CR51","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1097\/01.ASN.0000037677.16961.DF","volume":"13","author":"Groothoff","year":"2002","unstructured":"Groothoff J, Gruppen M, Offringa M, De Groot E, Stok W, Bos W, Davin J, Lilien M, Van De Kar N, Woff E, Heymans H (2002) Increased arterial stiffness in young adults with end-stage renal disease since childhood. J Am Soc Nephrol 13:2953\u20132961","journal-title":"J Am Soc Nephrol"},{"key":"1954_CR52","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s004670000303","volume":"14","author":"Mitsnefes","year":"2000","unstructured":"Mitsnefes MM, Daniels SR, Scwartz SM, Meyer RA, Khoury P, Strife CF (2000) Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol 14:898\u2013902","journal-title":"Pediatr Nephrol"},{"key":"1954_CR53","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/ndt\/16.10.2041","volume":"16","author":"Nayir","year":"2001","unstructured":"Nayir A, Bilge I, Kilicaslan I, Ander H, Emre S, Sirin A (2001) Arterial changes in paediatric haemodialysis patients undergoing renal transplantation. Nephrol Dial Transplant 16:2041\u20132047","journal-title":"Nephrol Dial Transplant"},{"key":"1954_CR54","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","volume":"342","author":"Goodman","year":"2000","unstructured":"Goodman W, Goldin J, Kuizon B, Chun Y, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff R, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Eng J Med 342:1478\u20131483","journal-title":"N Eng J Med"},{"key":"1954_CR55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s004670050022","volume":"14","author":"Silverstein","year":"2000","unstructured":"Silverstein D, Palmer J, Polinsky M, Braas C, Conley S, Baluarte H (2000) Risk factors for hyperlipidemia in long-term pediatric transplant recipients. Pediatr Nephrol 14:105\u2013110","journal-title":"Pediatr Nephrol"},{"key":"1954_CR56","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000046673","volume":"22","author":"Jacobson","year":"2002","unstructured":"Jacobson SH, Egverg N, Hylander B, Lundahl J (2002) Correlation between soluble markers of endothelial dysfunction in patients with chronic renal failure. Am J Nephrol 22:42\u201347","journal-title":"Am J Nephrol"},{"key":"1954_CR57","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1046\/j.1365-2362.2003.01169.x","volume":"33","author":"Zoccali","year":"2003","unstructured":"Zoccali C, Benedetto FA, Mallamaci F, Tripipi G, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Rapisarda F, Fatuzzo P, Seminara G, Nicocia G, Buemi M (2003) Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure. Eur J Clin Invest 33:561\u2013566","journal-title":"Eur J Clin Invest"},{"key":"1954_CR58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00004872-200301000-00024","volume":"21","author":"Turi","year":"2003","unstructured":"Turi S, Friedman A, Bereczki C, Papp F, Kovacs J, Karg E, Nemeth I (2003) Oxidative stress in juvenile essential hypertension. J Hypertens 21:145\u2013152","journal-title":"J Hypertens"},{"key":"1954_CR59","first-page":"1009","volume":"93","author":"Aggoun","year":"2000","unstructured":"Aggoun Y, Niaudet P, Laffont A, Sidi D, Kachaner J, Bonnet D (2000) Cardiovascular impact of end-stage renal insufficiency. Arch Mal Coeur Vaiss 93:1009\u20131013","journal-title":"Arch Mal Coeur Vaiss"},{"key":"1954_CR60","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.CIR.0000049744.23613.69","volume":"107","author":"Mitsnefes","year":"2003","unstructured":"Mitsnefes MM, Kimball TR, Witt SA, Glascock BJ, Khoury PR, Daniels SR (2003) Left ventricular mass and systolic performance in pediatric patients with chronic renal failure. Circulation 107:864\u2013868","journal-title":"Circulation"},{"key":"1954_CR61","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.yjmcc.2004.01.001","volume":"36","author":"Ma","year":"2004","unstructured":"Ma KK, Ogawa T, de Bold AJ (2004) Selective upregulation of cardiac brain natriuretic peptide at the transcriptional levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase. J Mol Cell Cardiol 36:505\u2013513","journal-title":"J Mol Cell Cardiol"},{"key":"1954_CR62","first-page":"641","volume":"16","author":"Nishimura","year":"2003","unstructured":"Nishimura M, Hashimoto T, Kobayashi H, et al (2003) Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients. J Nephrol 16:641\u2013649","journal-title":"J Nephrol"},{"key":"1954_CR63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00467-002-1030-z","volume":"18","author":"Mitsnefes","year":"2003","unstructured":"Mitsnefes MM, Kimball TR, Daniels SR (2003) Office and ambulatory blood pressure elevation in children with chronic renal failure. Pediatr Nephrol 18:145\u2013149","journal-title":"Pediatr Nephrol"},{"key":"1954_CR64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s004670050226","volume":"11","author":"Lingens","year":"1997","unstructured":"Lingens N, Dobos E, Witte K, Busch C, Lemmer B, Klaus G, Scharer K (1997) Twenty-four-hour ambulatory blood pressure profiles in pediatric patients after renal transplantation. Pediatr Nephrol 11:23\u201326","journal-title":"Pediatr Nephrol"},{"key":"1954_CR65","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.0000084539.58092.DE","volume":"108","author":"Node","year":"2003","unstructured":"Node K, Fujit M, Kitakaze M, Hori M, Liao JK (2003) Short-term statin therapy improves cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy. Circulation 108:839\u2013843","journal-title":"Circulation"},{"key":"1954_CR66","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0022-3476(97)70213-0","volume":"130","author":"Sanjad","year":"1997","unstructured":"Sanjad S, Al-Abbad A, Al-Shorafa S (1997) Management of hyperlipidemia in children with refractory nephritic syndrome: the effect of statin therapy. J Pediatr 130:470\u2013474","journal-title":"J Pediatr"},{"key":"1954_CR67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1399-3046.2003.02048.x","volume":"7","author":"Argent","year":"2003","unstructured":"Argent E, Kainer G, Aitken M, Rosenberg AR, Mackie F (2003) Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients. Pediatr Transplant 7:38\u201342","journal-title":"Pediatr Transplant"},{"key":"1954_CR68","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1161\/01.CIR.0000143073.60937.50","volume":"110","author":"Chong","year":"2004","unstructured":"Chong AY, Blann AD, Patel J, Freestone B, Hughes E, Lip GYH (2004) Endothelial dysfunction and damage in congestive heart failure. Relation of flow-mediated dilation to circulating endothelial cells, plasma indexes of endothelial damage and brain natriuretic peptide. Circulation 110:1794\u20131798","journal-title":"Circulation"},{"key":"1954_CR69","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0735-1097(00)01157-8","volume":"37","author":"Cheng","year":"2001","unstructured":"Cheng V, Kazanagra R, Garcia A, et al (2001) A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37:386\u2013391","journal-title":"J Am Coll Cardiol"},{"key":"1954_CR70","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0006-291X(91)90495-S","volume":"174","author":"Yokota","year":"1991","unstructured":"Yokota N, Yamamoto Y, Aburaya N, Kitamura K, Eto T, Kangawa K, et al (1991) Increased secretion of brain natriuretic peptide and atrial natriuretic peptide, but not sufficient to induce natriuresis in rats with nephrotic syndrome. Biochem Biophys Res Commun 174:128\u2013135","journal-title":"Biochem Biophys Res Commun"},{"key":"1954_CR71","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1046\/j.1523-1755.2001.0590041559.x","volume":"59","author":"Mallamaci","year":"2001","unstructured":"Mallamaci F, Zoccali C, Tripeti, et al (2001) Diagnostic potential of cardiac natriuretic peptides in dialysis patients. Kidney Int 59:1559\u20131566","journal-title":"Kidney Int"},{"key":"1954_CR72","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1681\/ASN.V1271508","volume":"12","author":"Zoccali","year":"2001","unstructured":"Zoccali C, Mallamaci F, Benedetto, et al (2001) Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 12:1508\u20131515","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-1954-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-005-1954-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-005-1954-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T19:52:15Z","timestamp":1626292335000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-005-1954-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8,5]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["1954"],"URL":"https:\/\/doi.org\/10.1007\/s00467-005-1954-1","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,8,5]]}}}